Clarifying the Survival Benefits of Moxibustion in Advanced Pulmonary Adenocarcinoma: Methodological Considerations

Podobne zapisy

• Moxibustion Treatment, Alongside Conventional Western and Chinese Herbal Medical Therapies, May Improve Survival in Stage-IV Pulmonary Adenocarcinomas in a Dosage-Dependent Manner: A Prospective Observational Study With Propensity Score Analysis
  od: Hegen Li MD, i wsp.
  Wydane: (2025-06-01)
• Clarifying the Survival Benefits of Moxibustion in Advanced Pulmonary Adenocarcinoma: Methodological Considerations
  od: Xingjian Wang MD, i wsp.
  Wydane: (2025-09-01)
• Real-world evidence of baseline soluble CD25 as a prognostic biomarker and indicator of differential EGFR–TKI benefit in stage IV lung adenocarcinoma
  od: Huiru Guo, i wsp.
  Wydane: (2026-07-01)
• Arginine methylation patterns in LUAD: defining prognostic subtypes and relevance to immunotherapy
  od: Qianyun Shen, i wsp.
  Wydane: (2025-05-01)
• Moxibustion in Stage-IV Pulmonary Adenocarcinoma: Towards Standardized Intervention Protocols and Mechanistic Integration
  od: Zhaoxin Wu, i wsp.
  Wydane: (2025-12-01)